Nongenotropic, Anti-Apoptotic Signaling of 1α,25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes
Open Access
- 1 April 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (14), 14130-14137
- https://doi.org/10.1074/jbc.m410720200
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and boneSteroids, 2004
- A specific binding protein/receptor for 1α,25-dihydroxyvitamin D3 is present in an intestinal caveolae membrane fractionBiochemical and Biophysical Research Communications, 2002
- 1 ,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein KinaseEndocrinology, 2002
- Osteoblast response to titanium surface roughness and 1?,25-(OH)2D3 is mediated through the mitogen-activated protein kinase (MAPK) pathwayJournal of Biomedical Materials Research, 2001
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- 1α,25‐Dihydroxyvitamin D3‐26,23‐lactone analogs antagonize differentiation of human leukemia cells (HL‐60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells)FEBS Letters, 1999
- 1 ,25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell DeathEndocrinology, 1999
- Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and CytokinesJournal of Bone and Mineral Research, 1998
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992